Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rysavá

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Vnitrni Lekarstvi|October 1, 2011
[Proteinuria in primary care]R Rysavá
Sbornik Lekarsky|January 1, 1996
[Brain disorders in autosomal dominant polycystic kidney disease]M Merta, R Rysavá
Sbornik Lekarsky|February 28, 2001
[Perspectives in gene therapy of polycystic kidney disease]M Merta, M Kohoutová, R Rysavá
Vnitrni Lekarstvi|June 15, 2006
[Urinary tract infection in patients with diabetes mellitus]M Merta, R Rysavá, V Tesar
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 21, 2003
Current therapeutic possibilities in primary and secondary amyloidosis and our experience with 31 patientsR Rysavá, M Merta, I Spicka, et al.
Ceskoslovenska Patologie|September 22, 2009
[Systemic amyloidoses in renal biopsy samples]L Bauerová, E Honsová, R Rysavá, et al.
Biochemistry and Molecular Biology International|June 12, 1999
Can serum amyloid A or macrophage colony stimulating factor serve as marker of amyloid formation process?R Rysavá, M Merta, V Tesar, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 21, 2003
Current treatment strategies in ANCA-positive renal vasculitis-lessons from European randomized trialsV Tesar, Z Ríhová, E Jancová, et al.
Casopis Lekaru Ceskych|August 20, 2003
[Is the current treatment of primary and secondary amyloidosis effective?]R Rysavá, I Spicka, M Merta, et al.
Sbornik Lekarsky|June 8, 1999
[Linear discrimination analysis in blood pressure monitoring]O Mestek, V Tesar, R Rysavá, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Vnitrni Lekarstvi|October 1, 2011
[Proteinuria in primary care]R Rysavá
Sbornik Lekarsky|January 1, 1996
[Brain disorders in autosomal dominant polycystic kidney disease]M Merta, R Rysavá
Sbornik Lekarsky|February 28, 2001
[Perspectives in gene therapy of polycystic kidney disease]M Merta, M Kohoutová, R Rysavá
Vnitrni Lekarstvi|June 15, 2006
[Urinary tract infection in patients with diabetes mellitus]M Merta, R Rysavá, V Tesar
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 21, 2003
Current therapeutic possibilities in primary and secondary amyloidosis and our experience with 31 patientsR Rysavá, M Merta, I Spicka, et al.
Ceskoslovenska Patologie|September 22, 2009
[Systemic amyloidoses in renal biopsy samples]L Bauerová, E Honsová, R Rysavá, et al.
Biochemistry and Molecular Biology International|June 12, 1999
Can serum amyloid A or macrophage colony stimulating factor serve as marker of amyloid formation process?R Rysavá, M Merta, V Tesar, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 21, 2003
Current treatment strategies in ANCA-positive renal vasculitis-lessons from European randomized trialsV Tesar, Z Ríhová, E Jancová, et al.
Casopis Lekaru Ceskych|August 20, 2003
[Is the current treatment of primary and secondary amyloidosis effective?]R Rysavá, I Spicka, M Merta, et al.
Sbornik Lekarsky|June 8, 1999
[Linear discrimination analysis in blood pressure monitoring]O Mestek, V Tesar, R Rysavá, et al.
Pageof 5